Latest Period
n/a
Security Snapshot
Fortress Biotech, Inc. - Common Stock, par value $0.0001 per share (FBIO) Institutional Ownership
CUSIP: 34960Q109
13F Institutional Holders and Ownership History from Q1 2015 to Q2 2024
Institutions Reporting
Shares (Excl. Options)
Price
Save this security page for your next review
Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.
- Security type / class
- Equity / Common Stock, par value $0.0001 per share
- Symbol
- FBIO on Nasdaq
- Shares outstanding
- 35,059,667
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors
Key facts
- FBIO - Fortress Biotech, Inc. - Common Stock, par value $0.0001 per share is tracked under CUSIP 34960Q109.
- Latest finished 13F holder period is not available.
- 1 significant owner is listed from Schedule 13D/13G reporting.
Change
- Holder count moved from 1 to 0 between Q1 2024 and Q2 2024.
- SEC-reported value moved from $42,006 to $0.
Research use
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Evidence
Source: SEC Schedule 13D/G
Open SEC evidence
Ownership context comes from Schedule 13D/G and available holder history for this CUSIP.
Security key
34960Q109
Latest holder period
n/a
13F holders
13D/G owners
1
CIK / CUSIP context first
FBIO full holder history
Fortress Biotech, Inc. SEC filings
Fortress Biotech, Inc. company facts
Fortress Biotech, Inc. insider transactions
Fortress Biotech, Inc. 13D/G history
Broader feeds
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 34960Q109:
13D/G owners
Significant owners
Large-stake holder rows connected to Schedule 13D/G evidence.
Rows
1
Security
FBIO
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | 7.8% | 2,734,654 | Highbridge Capital Management, LLC | 31 Mar 2026 |
Quarter history
Institutional holders across reporting periods
Holder count, reported shares/value, and median price by quarter.
Periods
38
Latest
n/a
Rows shown
1-25 of 38
| Period | 13F Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2024 Q2 | 0 | $0 | -$42,006 | 0 | |
| 2024 Q1 | 144,700 | $42,006 | +$42,006 | $0.29 | 1 |
| 2023 Q4 | 0 | $0 | -$5,746,547 | 0 | |
| 2023 Q3 | 19,809,063 | $5,749,187 | -$2,025,532 | $0.29 | 43 |
| 2023 Q2 | 24,149,052 | $13,278,866 | -$3,435,262 | $0.55 | 46 |
| 2023 Q1 | 28,425,069 | $23,306,552 | +$426,105 | $0.82 | 51 |
| 2022 Q4 | 27,497,866 | $18,009,174 | -$2,026,397 | $0.66 | 47 |
| 2022 Q3 | 29,999,838 | $25,794,770 | -$780,486 | $0.86 | 56 |
| 2022 Q2 | 30,820,541 | $25,882,668 | -$4,832,922 | $0.84 | 60 |
| 2022 Q1 | 35,590,426 | $48,404,672 | +$4,121,988 | $1.36 | 77 |
| 2021 Q4 | 31,748,690 | $79,363,187 | +$4,365,775 | $2.50 | 78 |
| 2021 Q3 | 30,257,618 | $97,454,567 | +$678,828 | $3.22 | 76 |
| 2021 Q2 | 30,005,418 | $107,116,199 | -$4,495,832 | $3.57 | 81 |
| 2021 Q1 | 31,269,164 | $110,368,273 | -$2,163,672 | $3.53 | 81 |
| 2020 Q4 | 31,890,183 | $101,129,398 | +$3,026,700 | $3.17 | 84 |
| 2020 Q3 | 26,981,923 | $108,992,555 | +$32,990,008 | $4.04 | 75 |
| 2020 Q2 | 22,594,538 | $60,554,070 | +$36,623,387 | $2.68 | 72 |
| 2020 Q1 | 9,185,993 | $17,362,233 | +$4,224,635 | $1.89 | 53 |
| 2019 Q4 | 6,851,537 | $17,601,676 | +$2,462,168 | $2.57 | 51 |
| 2019 Q3 | 6,597,888 | $9,303,785 | +$551,462 | $1.41 | 47 |
| 2019 Q2 | 6,173,403 | $9,260,643 | -$717,092 | $1.50 | 43 |
| 2019 Q1 | 6,540,627 | $11,626,335 | -$599,189 | $1.78 | 45 |
| 2018 Q4 | 7,101,953 | $6,106,878 | -$1,704,990 | $0.86 | 52 |
| 2018 Q3 | 8,435,451 | $13,710,475 | +$747,616 | $1.60 | 60 |
| 2018 Q2 | 7,590,340 | $22,619,672 | +$1,930,311 | $2.98 | 60 |